Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This is a Phase 1 study in which healthy volunteers and participants with chronic HBV infection will receive VIR-3434 or placebo and will be assessed for safety, tolerability, pharmacokinetics (PK), and antiviral activity (only in participants with chronic HBV infection).
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Healthy Volunteers:
Inclusion Criteria:
Exclusion Criteria:
CHB Patients:
Inclusion Criteria:
Exclusion Criteria:
Primary purpose
Allocation
Interventional model
Masking
113 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal